From November 20, 2023 to December 31, 2023, the company has repurchased 7,201,500 shares, representing 1.35% for CNY 95.84 million. With this, the company has completed the repurchase of 7,201,500 shares, representing 1.35% for CNY 95.84 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.51 CNY | +3.53% | 0.00% | -36.63% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.63% | 60Cr | |
-5.43% | 27TCr | |
-7.99% | 8.94TCr | |
-2.18% | 3.99TCr | |
-12.60% | 3.92TCr | |
-1.82% | 3.7TCr | |
-1.49% | 3.62TCr | |
-15.99% | 3TCr | |
-4.78% | 2.92TCr | |
+4.69% | 2.37TCr |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.